Omega Healthcare (OHI) AI Stock Analysis

Omega Healthcare

(BMV:OHI)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Revenue and profitability momentumRevenue has continued to rise and TTM profitability is materially stronger, indicating improved earnings capacity. Although reported margins have been volatile, the combination of top-line momentum and higher net margin can support investment, debt service, and shareholder distributions over the next several quarters.

Negative Factors

Sharp free-cash-flow decelerationThe recent decline in free-cash-flow growth weakens confidence in the consistency of internally generated cash, even though the absolute level remains healthy. Lower conversion versus prior years could constrain reinvestment, debt reduction, or distributions if the deceleration persists.

Omega Healthcare (OHI) vs. SPDR S&P 500 ETF (SPY)

Market Cap: MXN 14.24B
Dividend Yield: 5.45%
Average Volume (3M): 459
Price to Earnings (P/E): 16.3
Beta (1Y): 0.15
Revenue Growth: 4.81%
EPS Growth: 56.60%
Country: Mexico
Employees: 69
Sector: Real Estate
Sector Strength: 65
Industry: REIT - Healthcare Facilities

Omega Healthcare Business Overview & Revenue Model

Company Description

Omega Healthcare Investors, Inc. functions as a Real Estate Investment Trust (REIT) primarily focused on the long-term healthcare sector. The company strategically invests in properties providing skilled nursing and assisted living services. A divers...

Omega Healthcare Earnings Call Summary

Earnings Call Date:Jul 28, 2026(Q2-2026)|% Change Since:2.15%|Next Earnings Date:Nov 02, 2026

Earnings Call SentimentPositive

The call emphasized strong underlying fundamentals: year-over-year revenue and AFFO growth, significant liquidity and deleveraging, strategic asset sales executed at attractive economics, improved portfolio coverage, a robust investment pipeline (including first U.K. RIDEA), and a modestly tightened upward guidance. Near-term results are being muted by intentional strategic asset sales and loan repayments, and a small number of operator-specific issues (Genesis bankruptcy, Ciena transitions, localized occupancy gaps) and regulatory risks create some near-term uncertainty. Overall, management projects these actions will strengthen credit support and enable accretive redeployment in H2 2026 and 2027.

Positive Updates

Revenue and Earnings Growth Year-over-Year

Q2 2026 revenue was $328M vs $283M in Q2 2025, a year-over-year increase of approximately 15.9%. Net income available to common shareholders was $363M ($1.19/share) vs $137M ($0.46/share) in Q2 2025 (net income per share increased ~158.7% YoY, primarily reflecting a $247M gain on asset sales).

Negative Updates

Near-Term Earnings Headwind from Asset Sales and Loan Repayments

Management noted significant asset dispositions ($563M–$597M referenced) and ~$209M in loan repayments over the past two quarters that muted sequential AFFO growth. Neal indicated the timing of late-quarter sales and repayments reduced Q2 AFFO by approximately $7.5M and created a temporary headwind expected to impact Q3 as well. Guidance includes roughly $9M of quarterly revenue impact associated with assets sold/loans repaid.

Company Guidance

Omega tightened and raised full‑year adjusted FFO guidance to $3.22–$3.26 per share (midpoint $3.24, up $0.02 from April), reflecting a near‑term headwind of about $9 million of quarterly revenue tied to assets sold and loans repaid late in Q2; the guidance includes new investments closed as of July 29 but excludes other transactions, assumes $56 million converts to fee simple of $144 million of mortgages/loans maturing in 2026 and that $180 million of non‑real‑estate loans (including ~ $148 million of Genesis loans) will be repaid in 2026, contemplates continued portfolio pruning of $15–$25 million of asset sales per quarter, incorporates the $0.01 common dividend increase, and notes the high end of the range could benefit from timing or extensions of repayments/sales, additional cash‑basis operator payments, RIDEA and JV operating exposure, and lower G&A.

Omega Healthcare Risk Analysis

Omega Healthcare disclosed 37 risk factors in its most recent earnings report. Omega Healthcare reported the most risks in the "Finance & Corporate" category.

Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

Omega Healthcare Peers Comparison

Overall Rating

Financial Indicators

MX:OHI against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	65Neutral	$2.17B	12.19	3.79%	4.94%	3.15%	1.96%

* Real Estate Sector Average

Performance Comparison

MX:OHI and its peers over the selected period
Show on chart	Ticker	Company Name	Price	Change	% Change
	MX:OHI	Omega Healthcare Investors	857.25	101.77	13.47%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Omega Healthcare AI Stock Analysis